Covid-19 and the role of smoking: the protocol of the multicentric prospective study COSMO-IT (COvid19 and SMOking in ITaly).
Main Article Content
Keywords
COVID-19, lifestyle habits, prognosis, SARS-COV-2, smoking, tobacco, risk factors
Abstract
The emergency caused by Covid-19 pandemic raised interest in studying lifestyles and comorbidities as important determinants of poor Covid-19 prognosis. Data on tobacco smoking, alcohol consumption and obesity are still limited, while no data are available on the role of e-cigarettes and heated tobacco products (HTP). To clarify the role of tobacco smoking and other lifestyle habits on COVID-19 severity and progression, we designed a longitudinal observational study titled COvid19 and SMOking in ITaly (COSMO-IT). About 30 Italian hospitals in North, Centre and South of Italy joined the study. Its main aims are: 1) to quantify the role of tobacco smoking and smoking cessation on the severity and progression of COVID-19 in hospitalized patients; 2) to compare smoking prevalence and severity of the disease in relation to smoking in hospitalized COVID-19 patients versus patients treated at home; 3) to quantify the association between other lifestyle factors, such as e-cigarette and HTP use, alcohol and obesity and the risk of unfavourable COVID-19 outcomes. Socio-demographic, lifestyle and medical history information will be gathered for around 3000 hospitalized and 700-1000 home-isolated, laboratory-confirmed, COVID-19 patients. Given the current absence of a vaccine against SARS-COV-2 and the lack of a specific treatment for -COVID-19, prevention strategies are of extreme importance. This project, designed to highly contribute to the international scientific debate on the role of avoidable lifestyle habits on COVID-19 severity, will provide valuable epidemiological data in order to support important recommendations to prevent COVID-19 incidence, progression and mortality.
Downloads
References
2. Guan WJ, Ni ZY, Hu Y et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Apr 30; 382(18):1708-1720. doi: 10.1056/NEJMoa2002032
3. Zagà V, Gallus S, Gorini G, Cattaruzza MS. Why coronavirus is more deadly among men than among women? The smoking hypothesis. Tobaccology. 2020; 1:21-29
4. Palmieri L, Vanacore N, Donfrancesco C et al. Clinical Characteristics of Hospitalized Individuals Dying with COVID-19 by Age Group in Italy. J Gerontol A Biol Sci Med Sci. 2020 Jun 7;glaa146. doi: 10.1093/gerona/glaa146
5. Cattaruzza MS, Zagà V, Gallus S, D'Argenio P, Gorini G. Tobacco smoking and COVID-19 pandemic: old and new issues. A summary of the evidence from the scientific literature. Acta Biomed. 2020; 91(2):106-112. doi: 10.23750/abm.v91i2.9698
6. Gorini G, Clancy L, Fernandez E, Gallus S. Smoking history is an important risk factor for severe COVID-19. Blog Tob Control. 5 April 2020: https://blogs.bmj.com/tc/2020/04/05/smoking-history-is-an-important-risk-factor-for-severe-covid-19/
7. Reuters. Experts urge smokers and tobacco firms to quit for COVID-19. 6 April 2020: https://uk.reuters.com/article/ushealth-coronavirus-tobacco/experts-urge-smokers-and-tobacco-firms-to-quit-for-covid-19-idUKKBN21O1KG
8. Zhang JJ, Dong X, Cao YY et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy 2020; 75:1730-41. doi: 10.1111/all.14238
9. Pacifici R. Covid-19: nei fumatori il rischio di finire in terapia intensiva è più del doppio. Istituto Superiore di Sanità, 2020: https://www.iss.it/web/guest/primo-piano/-/asset_publisher/o4oGR9qmvUz9/content/id/5294087
10. Simons D, Shahab L, Brown J, Perski O. The association of smoking status with SARS-CoV-2 infection, hospitalization and mortality from COVID-19: a living rapid evidence review. (version 4). Jun 11, 2020; Qeios ID: UJR2AW.4; https://doi.org/10.32388/UJR2AW.5.
11. Brake SJ, Barnsley K, Lu W et al. Smoking Upregulates Angiotensin-Converting Enzyme-2 Receptor: A Potential Adhesion Site for Novel Coronavirus SARS-CoV-2 (Covid-19). J Clin Med. 2020;9(3):841. doi: 10.3390/jcm9030841
12. Lighter J, Phillips M, Hochman S et al. Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission. Clin Infect Dis. 2020; 71(15):896-897. doi: 10.1093/cid/ciaa415
13. Simonnet A, ChetbounM, Poissy J et al. High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Obesity. 2020; 28(7):1195-1199. doi: 10.1002/oby.22831
14. Riedel F, Goessler UR, Hormann K. Alcohol-related diseases of the mouth and throat. Dig Dis. 2005;23(3-4):195-203. doi: 10.1159/000090166
15. Simou E, Britton J, Leonardi-Bee J. Alcohol and the risk of pneumonia: a systematic review and meta-analysis. BMJ Open. 2018 Aug 22;8(8):e022344. doi: 10.1136/bmjopen-2018-022344